Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2018 / Cilt: 52 - Sayı: 4

Papular mucinosis: A report of two cases

Papüler müsinozis: İki olgu sunumu

Pages
142–145
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper, we present two cases of PM with no associated monoclonal gammopathy in two male patients aged 75 and38 years, for its rare occurrence in the literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Papular mucinosis (PM) (lichen myxoedematosus) is a unique, chronic idiopathic disease characterized by lichenoid papules or nodules due todermal mucin deposition and a variable degree of fibrosis.
📊
Key Findings & Data:PM is a quite rare disease of unknown etiology, with fewer than one hundred andfifty cases reported.
💡
Conclusion & Impact:In this paper, we present two cases of PM with no associated monoclonal gammopathy in two male patients aged 75 and38 years, for its rare occurrence in the literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Papular mucinosis (PM) (lichen myxoedematosus) is a unique, chronic idiopathic disease characterized by lichenoid papules or nodules due todermal mucin deposition and a variable degree of fibrosis. PM is a quite rare disease of unknown etiology, with fewer than one hundred andfifty cases reported. In this paper, we present two cases of PM with no associated monoclonal gammopathy in two male patients aged 75 and38 years, for its rare occurrence in the literature.

Özet

Papüler müsinozis (PM) (liken miksödematozis) likenoid papüller ve nodüller, dermal müsin birikimi ve değişken derecedeki fibrozis ile karakterize derinin oldukça nadir, kronik ve idiyopatik bir hastalığıdır. PM etiyolojisi bilinmeyen, literatürde yüz elli olgudan daha az bildirilmiş olan, oldukça nadir görülen bir hastalıktır. Literatürde seyrek görülmesi nedeniyle ek bir hastalıkla ilişkili olmayan iki PM olgumuzu sunmak istedik. Burada, 75 ve 38 yaşında iki erkek PM’li hasta monoklonal gammopati olmaksızın nadir olarak görüldüğünden dolayı sunulmaktadır.

🔖

Cite This Article

ÖZER, İ., ATASEVEN, A., FINDIK, S., TEMİZ, S. A., DURSUN, R. (2022). Papular mucinosis: A report of two cases. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 52 - Sayı: 4, 142–145. https://ajindex.com/articles/621692

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Popović D, Paravina M, Jovanović D, et al: Scleromyxedema (Arndt Gottron Syndrome): a Case Report. Serbian Journal of Dermatology and Venereology 2016;8:28-38.
  2. Allam M, Ghozzi M: Scleromyxedema: a case report and review of the literature. Case Rep Dermatol 2013;5:68-175.
  3. Akış HK, Eskioğlu F, Öztürk E: “Diskret” Papüler Müsinoz: Liken Miksödematozun Nadir Bir Subtipi. Turkderm 2011;45:104-6.
  4. Mehta V, Balachandran C, Rao R: Arndt Gottron scleromyxedema: successful response to treatment with steroid minipulse and methotrexate. Indian J Dermatol 2009;54:193-5.
  5. Rebellato PR, Carbonar MB, Tabuti NI, Rastelli GJ: Case for diagnosis. Lichen myxedematosus. An Bras Dermatol 2016;91:842-3.
  6. Rongioletti F, Rebora A: Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol 2001;44:273-81.
  7. Burns DA, Breathnach SM, Cox N, Griffiths C: Rook’s Textbook of Dermatology. 2004.
  8. Concheiro J, Pérez-Pérez L, Peteiro C, Labandeira J, Toribio J: Discrete papular lichen myxoedematosus: a rare subtype of cutaneous mucinosis. Clin Exp Dermatol 2009;34:608. Finkel LJ, Headington JT: Cutaneous mucinosis and amyloidosis. Dermatology 1992;3:1597-602.
  9. Blum M, Wigley FM, Hummers LK: Scleromyxedema: a case series highlighting long-term outcomes of treatment with intravenous immunoglobulin (IVIG). Medicine (Baltimore) 2008;87:10-20.
  10. Cokonis Georgakis CD, Falasca G, Georgakis A, Heymann WR: Scleromyxedema. Clin Dermatol 2006;24:493-7.
  11. Lopez L, Wierzbicka-Hainaut E, Villers A, Guillet G: Efficacy of intravenous immunoglobulin in Arndt-Gottron scleromyxedema. Ann Dermatol Venereol 2009;136:330-6.
  12. Efthimiou P, Blanco M: Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature. Semin Arthritis Rheum 2008;38:188-94.
  13. Serdar ZA, Altunay IK, Yasar SP, Erfan GT, Gunes P: Generalized papular and sclerodermoid eruption: Scleromyxedema. Indian J Dermatol Venereol Leprol 2010;76:592. Brenner M, Herzinger T, Berking C, Plewig G, Degitz K: Phototherapy and photochemotherapy of sclerosing skin diseases. Photodermatol Photoimmunol Photomed 2005;21:157-65.
  14. Rampino M, Garibaldi E, Ragona R, Ricardi U: Scleromyxedema: treatment of widespread cutaneous involvement by total skin electron-beam therapy. Int J Dermatol 2007;46:864-7.
  15. Ataergin S, Arpaci F, Demiriz M, Ozet A: Transient efficacy of double highdose chemotherapy and autologous peripheral stem cell transplan